Arlington Financial Advisors LLC Buys 27,920 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Arlington Financial Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 201.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,783 shares of the exchange traded fund’s stock after purchasing an additional 27,920 shares during the quarter. Arlington Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,965,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Concourse Financial Group Securities Inc. boosted its position in shares of SPDR S&P Biotech ETF by 21.2% during the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after purchasing an additional 115 shares in the last quarter. Verity Asset Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 0.8% in the 4th quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock worth $1,551,000 after acquiring an additional 140 shares during the last quarter. Greenwich Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 1.4% in the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock worth $1,022,000 after acquiring an additional 155 shares during the last quarter. Mesirow Institutional Investment Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 3.2% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 5,565 shares of the exchange traded fund’s stock worth $497,000 after acquiring an additional 170 shares during the last quarter. Finally, HB Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 4.9% in the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after acquiring an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.2 %

Shares of XBI traded down $0.15 on Friday, reaching $92.71. The company’s stock had a trading volume of 7,872,582 shares, compared to its average volume of 10,728,328. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a market capitalization of $7.07 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average of $89.95 and a 200-day moving average of $90.80.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.